Mariner
CRL icon

Mariner’s Charles River Laboratories CRL Stock Holding History

Mariner’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,776
Closed -$996K – 3589
2026
Q1 		$996K Sell
5,776
-5,075
-47% -$941K ﹤0.01% 1975
2025
Q4 		$2.17M Sell
10,851
-7,505
-41% -$1.36M ﹤0.01% 1448
2025
Q3 		$2.87M Buy
18,356
+1,492
+9% +$237K ﹤0.01% 1214
2025
Q2 		$2.56M Sell
16,864
-1,705
-9% -$227K ﹤0.01% 1187
2025
Q1 		$2.8M Sell
18,569
-1,079
-5% -$181K ﹤0.01% 1064
2024
Q4 		$3.63M Sell
19,648
-427
-2% -$82.3K 0.01% 922
2024
Q3 		$3.95M Buy
20,075
+259
+1% +$53.8K 0.01% 875
2024
Q2 		$4.09M Buy
19,816
+3,944
+25% +$894K 0.01% 804
2024
Q1 		$4.3M Buy
15,872
+237
+2% +$56.6K 0.01% 789
2023
Q4 		$3.7M Buy
15,635
+6,071
+63% +$1.19M 0.01% 799
2023
Q3 		$1.87M Sell
9,564
-64
-0.7% -$13.1K 0.01% 1002
2023
Q2 		$2.02M Sell
9,628
-652
-6% -$130K 0.01% 972
2023
Q1 		$2.07M Sell
10,280
-1,147
-10% -$260K 0.01% 938
2022
Q4 		$2.49M Buy
11,427
+1,976
+21% +$432K 0.01% 834
2022
Q3 		$1.86M Buy
+9,451
New +$2.04M 0.01% 802

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mariner's CRL Position: Q2 2026 in Review

Mariner sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 5,776 shares — an estimated $996K sold.

Mariner first reported a position in CRL in Q3 2022 and held it in 15 quarters. The position peaked at $4.3M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Mariner reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 5,776 Charles River Laboratories shares in Q2 2026, an estimated $996K.
  • Mariner first reported a position in Charles River Laboratories in Q3 2022 and held it in 15 quarters.
  • Mariner's Charles River Laboratories position peaked at $4.3M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.